OnKure Therapeutics Rings the Closing Bell
About This Event
OnKure Therapeutics (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Nicholas Saccomano, President and Chief Executive Officer rings the Closing Bell.